These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 7538595)

  • 1. Enhanced chemoresistance by elevation of p185neu levels in HER-2/neu-transfected human lung cancer cells.
    Tsai CM; Yu D; Chang KT; Wu LH; Perng RP; Ibrahim NK; Hung MC
    J Natl Cancer Inst; 1995 May; 87(9):682-4. PubMed ID: 7538595
    [No Abstract]   [Full Text] [Related]  

  • 2. Suppressed transformation and induced differentiation of HER-2/neu-overexpressing breast cancer cells by emodin.
    Zhang L; Chang CJ; Bacus SS; Hung MC
    Cancer Res; 1995 Sep; 55(17):3890-6. PubMed ID: 7543819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p185neu is phosphorylated on tyrosine in human primary breast tumors which overexpress neu/erbB-2.
    Wildenhain Y; Pawson T; Blackstein ME; Andrulis IL
    Oncogene; 1990 Jun; 5(6):879-83. PubMed ID: 1694290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sensitization of HER-2/neu-overexpressing non-small cell lung cancer cells to chemotherapeutic drugs by tyrosine kinase inhibitor emodin.
    Zhang L; Hung MC
    Oncogene; 1996 Feb; 12(3):571-6. PubMed ID: 8637714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlations between intrinsic chemoresistance and HER-2/neu gene expression, p53 gene mutations, and cell proliferation characteristics in non-small cell lung cancer cell lines.
    Tsai CM; Chang KT; Wu LH; Chen JY; Gazdar AF; Mitsudomi T; Chen MH; Perng RP
    Cancer Res; 1996 Jan; 56(1):206-9. PubMed ID: 8548764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tyrosine kinase inhibitor emodin suppresses growth of HER-2/neu-overexpressing breast cancer cells in athymic mice and sensitizes these cells to the inhibitory effect of paclitaxel.
    Zhang L; Lau YK; Xia W; Hortobagyi GN; Hung MC
    Clin Cancer Res; 1999 Feb; 5(2):343-53. PubMed ID: 10037184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. c-erbB-2/neu overexpression enhances metastatic potential of human lung cancer cells by induction of metastasis-associated properties.
    Yu D; Wang SS; Dulski KM; Tsai CM; Nicolson GL; Hung MC
    Cancer Res; 1994 Jun; 54(12):3260-6. PubMed ID: 7911396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of p185neu kinase activity and cellular transformation by co-expression of a truncated neu protein.
    Qian X; O'Rourke DM; Zhao H; Greene MI
    Oncogene; 1996 Nov; 13(10):2149-57. PubMed ID: 8950982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absence of autophosphorylation site Y882 in the p185neu oncogene product correlates with a reduction of transforming potential.
    Zhang HT; O'Rourke DM; Zhao H; Murali R; Mikami Y; Davis JG; Greene MI; Qian X
    Oncogene; 1998 Jun; 16(22):2835-42. PubMed ID: 9671404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of a naturally occurring EGFR oncoprotein by the p185neu ectodomain: implications for subdomain contributions to receptor assembly.
    O'Rourke DM; Nute EJ; Davis JG; Wu C; Lee A; Murali R; Zhang HT; Qian X; Kao CC; Greene MI
    Oncogene; 1998 Mar; 16(9):1197-207. PubMed ID: 9528862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tyrosine kinase inhibitors, emodin and its derivative repress HER-2/neu-induced cellular transformation and metastasis-associated properties.
    Zhang L; Lau YK; Xi L; Hong RL; Kim DS; Chen CF; Hortobagyi GN; Chang C; Hung MC
    Oncogene; 1998 Jun; 16(22):2855-63. PubMed ID: 9671406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of a neu/c-erbB-2 protein-specific activating factor.
    Dobashi K; Davis JG; Mikami Y; Freeman JK; Hamuro J; Greene MI
    Proc Natl Acad Sci U S A; 1991 Oct; 88(19):8582-6. PubMed ID: 1717981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiserum raised against a synthetic phosphotyrosine-containing peptide selectively recognizes p185neu/erbB-2 and the epidermal growth factor receptor.
    Bangalore L; Tanner AJ; Laudano AP; Stern DF
    Proc Natl Acad Sci U S A; 1992 Dec; 89(23):11637-41. PubMed ID: 1280833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Curcumin inhibits tyrosine kinase activity of p185neu and also depletes p185neu.
    Hong RL; Spohn WH; Hung MC
    Clin Cancer Res; 1999 Jul; 5(7):1884-91. PubMed ID: 10430096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of HER-2/neu overexpression on chemotherapeutic drug sensitivity in human breast and ovarian cancer cells.
    Pegram MD; Finn RS; Arzoo K; Beryt M; Pietras RJ; Slamon DJ
    Oncogene; 1997 Jul; 15(5):537-47. PubMed ID: 9247307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of the neu gene-encoded protein (P185neu) in human non-small cell carcinomas of the lung.
    Weiner DB; Nordberg J; Robinson R; Nowell PC; Gazdar A; Greene MI; Williams WV; Cohen JA; Kern JA
    Cancer Res; 1990 Jan; 50(2):421-5. PubMed ID: 1967224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncogenic activation of the PDGF beta receptor by the transmembrane domain of p185neu*.
    Petti LM; Irusta PM; DiMaio D
    Oncogene; 1998 Feb; 16(7):843-51. PubMed ID: 9484775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tyrosine phosphorylation of Shc proteins and formation of Shc/Grb2 complex correlate to the transformation of NIH3T3 cells mediated by the point-mutation activated neu.
    Xie Y; Li K; Hung MC
    Oncogene; 1995 Jun; 10(12):2409-13. PubMed ID: 7784091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell cycle-dependent regulation of p185neu: a relationship between disruption of this regulation and transformation.
    Kiyokawa N; Yan DH; Brown ME; Hung MC
    Proc Natl Acad Sci U S A; 1995 Feb; 92(4):1092-6. PubMed ID: 7862640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of intrinsic chemoresistance of non-small-cell lung cancer cell lines with HER-2/neu gene expression but not with ras gene mutations.
    Tsai CM; Chang KT; Perng RP; Mitsudomi T; Chen MH; Kadoyama C; Gazdar AF
    J Natl Cancer Inst; 1993 Jun; 85(11):897-901. PubMed ID: 8098377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.